Your AI-Trained Oncology Knowledge Connection!
Opinion
Video
Experts discuss what they share with patients when counseling or introducing chimeric antigen receptor (CAR) T-cell therapy, focusing on the treatment process, potential benefits, risks, and expectations.
Video content above is prompted by the following:
Apr 17th 2025 - May 23rd 2025
Apr 8th 2025 - May 14th 2025
Apr 7th 2025 - Apr 8th 2026
Apr 18th 2025 - Apr 19th 2026
Apr 17th 2025 - May 23rd 2025
Apr 17th 2025 - May 23rd 2025
Apr 8th 2025 - May 14th 2025
Apr 7th 2025 - Apr 8th 2026
Apr 18th 2025 - Apr 19th 2026
Apr 17th 2025 - May 23rd 2025
Apr 17th 2025 - May 23rd 2025
Apr 8th 2025 - May 14th 2025
Apr 7th 2025 - Apr 8th 2026
Overview of iMMagine-1 Trial: Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of R/R MM
Application of Real-World Evidence in Selecting CAR T in R/R MM
Addition of Daratumumab to Lenalidomide Maintenance Boosts MRD-Negative Conversions in Myeloma Following ASCT
Apalutamide Boosts 24-Month OS in Real-World Population With Metastatic Castration-Sensitive Prostate Cancer
2 Commerce Drive
Cranbury, NJ 08512